Reported Earlier, Roche's Genentech Announced Data From Stage 1 Of The National Institutes Of Health (NIH)-Sponsored Pivotal Phase III Outmatch Study Evaluating The Efficacy And Safety Ofxolair
Reported Earlier, Roche's Genentech Announced Data From Stage 1 Of The National Institutes Of Health (NIH)-Sponsored Pivotal Phase III Outmatch Study Evaluating The Efficacy And Safety Ofxolair
早些时候报道，罗氏基因泰克公布了美国国立卫生研究院（NIH）赞助的评估Ofxolair疗效和安全性的关键性III期胜出研究第一阶段的数据
– Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed without an allergic reaction –
— 美国国立卫生研究院赞助的III期OutMatch研究的详细结果显示，使用Xolair进行治疗可增加年仅1岁的人在没有过敏反应的情况下食用的花生、木本坚果、鸡蛋、牛奶和小麦的摄入量 —
– The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies –
— 美国食品药品管理局最近批准Xolair作为第一种也是唯一一种针对一种或多种食物过敏的儿童和成人的药物—
– Allergic reactions can be life-threatening and it is estimated that food-related anaphylaxis results in 30,000 medical events treated in emergency rooms in the U.S. each year –
— 过敏反应可能危及生命，据估计，与食物相关的过敏反应每年导致美国急诊室治疗30,000起医疗事件 —